Category: Diseases & Conditions
Diseases & Conditions market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Colerectal Cancers
The 2025-2030 World Outlook for Colerectal Cancers This study covers the world outlook for colerectal cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Alzheimer's Treatments
The 2025-2030 World Outlook for Alzheimer's Treatments This study covers the world outlook for Alzheimer's treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Antidepressants
The 2025-2030 World Outlook for Antidepressants This study covers the world outlook for antidepressants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Antidepressants for Major Depressive Disorders
The 2025-2030 World Outlook for Antidepressants for Major Depressive Disorders This study covers the world outlook for antidepressants for major depressive disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for Antiemetic Chemotherapy Drugs
The 2025-2030 World Outlook for Antiemetic Chemotherapy Drugs This study covers the world outlook for antiemetic chemotherapy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency Diseases
The 2025-2030 World Outlook for Primary Immunodeficiency Diseases This study covers the world outlook for primary immunodeficiency diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Mental Health Care Software and Services
The 2025-2030 World Outlook for Mental Health Care Software and Services This study covers the world outlook for mental health care software and services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Antihypertensives
The 2025-2030 World Outlook for Antihypertensives This study covers the world outlook for antihypertensives across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Bleeding Disorder Drugs
The 2025-2030 World Outlook for Bleeding Disorder Drugs This study covers the world outlook for bleeding disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Mental Health and Intellectual Disability Facilities
The 2025-2030 World Outlook for Mental Health and Intellectual Disability Facilities This study covers the world outlook for mental health and intellectual disability facilities across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More
-
The 2025-2030 World Outlook for Anti-Malarial Drugs
The 2025-2030 World Outlook for Anti-Malarial Drugs This study covers the world outlook for anti-malarial drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Patient Derived Xenografts
The 2025-2030 World Outlook for Patient Derived Xenografts This study covers the world outlook for patient derived xenografts across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests
The 2025-2030 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests This study covers the world outlook for viral hepatitis and retrovirus diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Kidney Cancer Drugs
The 2025-2030 World Outlook for Kidney Cancer Drugs This study covers the world outlook for kidney cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Sphygmomanometers
The 2025-2030 World Outlook for Sphygmomanometers This study covers the world outlook for sphygmomanometers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Hematological Disorder Drugs and Diagnostics
The 2025-2030 World Outlook for Hematological Disorder Drugs and Diagnostics This study covers the world outlook for hematological disorder drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Hemophilia a Gene Therapies
The 2025-2030 World Outlook for Hemophilia a Gene Therapies This study covers the world outlook for hemophilia a gene therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Hemophilia a Treatments
The 2025-2030 World Outlook for Hemophilia a Treatments This study covers the world outlook for hemophilia a treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for PDX Models
The 2025-2030 World Outlook for PDX Models This study covers the world outlook for PDX models across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for Hematological Cancer Treatments
The 2025-2030 World Outlook for Hematological Cancer Treatments This study covers the world outlook for hematological cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Cutaneous Melanoma Therapeutics
The 2025-2030 World Outlook for Cutaneous Melanoma Therapeutics This study covers the world outlook for cutaneous melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Hemophilia Drugs
The 2025-2030 World Outlook for Hemophilia Drugs This study covers the world outlook for hemophilia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Patient Derived Xenograft-PDX Mouse Models
The 2025-2030 World Outlook for Patient Derived Xenograft-PDX Mouse Models This study covers the world outlook for patient derived xenograft-PDX mouse models across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Epilepsy Treatments
The 2025-2030 World Outlook for Epilepsy Treatments This study covers the world outlook for epilepsy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Crohn's Diseases
The 2025-2030 World Outlook for Crohn's Diseases This study covers the world outlook for Crohn's diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
Research Assistance
